The very same treatment that thwarts breast cancer has a dark side -- it can fuel the spread of the disease to the lungs. The front-line chemotherapy drug paclitaxel sets off a variety of molecular-level changes that allow breast cancer cells to escape from the tumour.
The very same treatment that thwarts breast cancer has a dark side – it can fuel the spread of the disease to the lungs. Researchers found clues to why it happens, opening up the possibility of interfering with the medication’s downsides while preserving its cancer-fighting.
For years, doctors have warned women that taking hormone replacement therapy, or HRT, may be linked with an increased risk of breast cancer. Back in , results from the WHI showed that HRT in the form of an estrogen and progesterone combination was associated with an increased.
Chemotherapy-induced early menopause occurred significantly less often in premenopausal breast cancer patients treated with a gonadotropin-releasing.